circ_PTN contributes to -cisplatin resistance in glioblastoma via PI3K/AKT signaling through the miR-542-3p/PIK3R3 pathway

• Main Authors: Hongcheng Luo (Author), Tingzhuang Yi (Author), Deyou Huang (Author), Xiaoping Chen (Author), Xu Li (Author), Qianquan Wan (Author), Haineng Huang (Author), Huadong Huang (Author), Hongyu Wei (Author), Ye Song (Author), Tianshi Que (Author), Rentong Hu (Author), Huatuo Huang (Author), Kunxiang Luo (Author), Chuanyu Li (Author), Chengjian Qin (Author), Chuanhua Zheng (Author), Chuanliu Lan (Author), Wencheng Chen (Author), Dan Zhou (Author), Qisheng Luo (Author)
• Format: Book
• Published: Elsevier, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Glioblastoma has been identified as the most common and aggressive primary brain tumor in adults. Recently, it has been found that cisplatin (DDP) treatment is a common chemotherapeutic method for GBM patients. circ_PTN (ID number: hsa_circ_0003949) is a newly found circular (circRNA) which has been...